(Q40717129)

English

Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children

scientific article published on June 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

membrane protein

1 reference

based on heuristic

inferred from title

author name string

G Kanra

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

M Ceyhan

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

D Vandevoorde

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

H Bogaerts

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 1993

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

European Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

152

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

478-483

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components

1 reference

https://api.crossref.org/works/10.1007%2FBF01955054

21 January 2018

Evaluation of a new highly purified pertussis vaccine in infants and children

1 reference

https://api.crossref.org/works/10.1007%2FBF01955054

21 January 2018

Protective Activities of the Filamentous Hemagglutinin and the Lymphocytosis-Promoting Factor of Bordetella pertussis in Mice

1 reference

https://api.crossref.org/works/10.1007%2FBF01955054

21 January 2018

Human serum antibody responses to Bordetella pertussis infection and pertussis vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of an acellular pertussis vaccine and its administration as a booster in healthy adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Booster response to acellular pertussis vaccine in children primed with acellular or whole cell vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sixteen-month follow-up of antibodies to pertussis toxin after primary immunization with acellular or whole cell vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pertussis Toxin: The Cause of the Harmful Effects and Prolonged Immunity of Whooping Cough. A Hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Developments in pertussis immunisation in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8335014

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01955054

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40717129&oldid=2203917281"